HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Interleukin-6 Prevents the Initiation but Enhances the Progression of Lung Cancer.

Abstract
Recent studies suggest that high expression of the proinflammatory cytokine IL6 is associated with poor survival of lung cancer patients. Accordingly, IL6 has been a target of great interest for lung cancer therapy. However, the role of IL6 in lung cancer has not been determined yet. Here, we demonstrate that IL6 plays opposite roles in the initiation and growth of lung cancer in a mouse model of lung cancer induced by the K-Ras oncogene. We find that compared with wild-type mice, IL6-deficient mice developed much more lung tumors after an activating mutant of K-Ras was induced in the lungs. However, lung tumors developed in IL6-deficient mice were significantly smaller. Notably, both the lung tumor-suppressing and -promoting functions of IL6 involve its ability in activating the transcription factor STAT3. IL6/STAT3 signaling suppressed lung cancer initiation through maintaining lung homeostasis, regulating lung macrophages, and activating cytotoxic CD8 T cells under K-Ras oncogenic stress, whereas it promoted lung cancer cell growth through inducing the cell proliferation regulator cyclin D1. These studies reveal a previously unexplored role of IL6/STAT3 signaling in maintaining lung homeostasis and suppressing lung cancer induction. These studies also significantly improve our understanding of lung cancer and provide a molecular basis for designing IL6/STAT3-targeted therapies for this deadliest human cancer.
AuthorsZhaoxia Qu, Fan Sun, Jingjiao Zhou, Liwen Li, Steven D Shapiro, Gutian Xiao
JournalCancer research (Cancer Res) Vol. 75 Issue 16 Pg. 3209-15 (Aug 15 2015) ISSN: 1538-7445 [Electronic] United States
PMID26122841 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Copyright©2015 American Association for Cancer Research.
Chemical References
  • Chemokines
  • Interleukin-6
  • KRAS protein, human
  • Proto-Oncogene Proteins
  • STAT3 Transcription Factor
  • Interleukin-10
  • Cyclin D1
  • Nitric Oxide Synthase Type II
  • Nos2 protein, mouse
  • Hras protein, mouse
  • Proto-Oncogene Proteins p21(ras)
  • ras Proteins
Topics
  • Animals
  • CD8-Positive T-Lymphocytes (immunology, metabolism)
  • Cell Proliferation
  • Chemokines (genetics, metabolism)
  • Cyclin D1 (genetics, metabolism)
  • Disease Progression
  • Gene Expression
  • Homeostasis
  • Immunohistochemistry
  • Interleukin-10 (genetics, metabolism)
  • Interleukin-6 (deficiency, genetics)
  • Lung (immunology, metabolism, pathology)
  • Lung Neoplasms (genetics, metabolism, pathology)
  • Macrophages (immunology, metabolism)
  • Mice, Knockout
  • Mutation
  • Nitric Oxide Synthase Type II (genetics, metabolism)
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins p21(ras) (genetics, metabolism)
  • Reverse Transcriptase Polymerase Chain Reaction
  • STAT3 Transcription Factor (genetics, metabolism)
  • Signal Transduction
  • ras Proteins

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: